Abraham Gitterman focuses on FDA and Healthcare regulatory, compliance, and fraud and abuse matters involving pharmaceutical and medical device manufacturers. He regularly counsels clients on FDA-regulated advertising and promotion, including use of social media; compliant medical affairs activities, including continuing medical education (CME); appropriate interactions with healthcare professionals; and mobile health applications. Mr. Gitterman also assists with extensive reviews of corporate compliance programs, both generally and pursuant to Corporate Integrity Agreements (CIAs) with OIG, for various life science companies and healthcare entities to ensure compliance with the Anti-Kickback Statute; the False Claims Act; and the Federal Food, Drug, and Cosmetic Act. Mr. Gitterman also has extensive experience counseling clients on the Physician Payments Sunshine Act and related state transparency and "gift ban" laws. He also advises clients on compliance with the Drug Supply Chain Security Act (DSCSA) and the Compounding Quality Act.
Prior to joining the firm, Mr. Gitterman was a research associate at a national ACCME-accredited CME provider, where he assisted drafting medical education grant applications and evaluated various conflict of interest policies regarding physician relationships with manufacturers. Mr. Gitterman received a Health Law Certificate from the Law & Health Care Program at the University of Maryland Francis King Carey School of Law. During law school, Mr. Gitterman clerked with the US Department of Justice, Consumer Protection Branch; The Office of Counsel to the Inspector General for the Department of Health and Human Services (OCIG); and The FDA Office of Policy. Mr. Gitterman also founded the Health Law Regulatory & Compliance Competition.
- Counsel various pharmaceutical manufacturers in assessing the FDA and healthcare compliance risks associated with medical and commercial activities and planning.
- Serve as outside counsel to various pharmaceutical manufacturers for the review of promotional and medical materials, including serving on promotional and medical review committees.
- Assisting various drug and device manufacturers understand the FDA, FTC, and healthcare regulatory framework for digital health products, including mobile medical applications, general wellness products, clinical decision support tools, and other health IT products.
- Advise various drug and device manufacturers on best practices for compliant medical affairs interactions, promotional activities, payor communications, patient interactions, reimbursement support, and use of social media, as well as interactions healthcare professionals (HCPs) and healthcare institutions.
- Various pharmaceutical manufacturers in conducting extensive audits and reviews of their medical affairs functions, including medical science liaison activities and interactions.
- Counsel various drug and device manufacturers by providing strategic legal counseling on various federal and state track and trace, supply chain, distribution, and licensure issues, including compliance with the Drug Supply Chain Security Act (DSCSA) and state wholesale drug distribution, dispensing, and 3PL laws.
1st Place, Fifteenth Annual Epstein Becker & Green Annual Health Law Writing Competition (2013)
Runner-Up, 11th Annual American Bar Association Health Law Student Writing Competition
- JD, University of Maryland Francis King Carey School of Law, 2013, magna cum laude, Order of the Coif
- BA, History, Pennsylvania State University, 2008
- BA, Political Science, Pennsylvania State University, 2008
- BA, Criminal Justice, Pennsylvania State University, 2008
- District of Columbia
- New Jersey